Beta Bionics Inc. (BBNX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Beta Bionics Inc.

NASDAQ: BBNX · Real-Time Price · USD
22.26
1.77 (8.64%)
At close: Oct 03, 2025, 3:59 PM
22.26
0.00%
After-hours: Oct 03, 2025, 04:35 PM EDT

Beta Bionics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Net Income
-54.76M -44.1M -64.75M
Depreciation & Amortization
2.28M 2.09M 2.1M
Stock-Based Compensation
6.38M 5.66M 6.1M
Other Working Capital
5.39M -682K -2.53M
Other Non-Cash Items
9.96M 10.27M -1.12M
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
-12.15M -6.36M -2.53M
Operating Cash Flow
-48.27M -32.45M -60.21M
Capital Expenditures
-3.4M -402K -772K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-72.13M n/a n/a
Sales Maturities Of Investments
72M n/a n/a
Other Investing Acitivies
50K -69.29M 3K
Investing Cash Flow
-3.48M -69.69M -769K
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
n/a 101.03M 56.78M
Financial Cash Flow
55.62M 101.03M 56.78M
Net Cash Flow
3.87M -1.11M 27.77M
Free Cash Flow
-51.67M -32.85M -60.98M